Skip to content
knowrare
HealthSignal
Your condition community

Living with Hurthle cell carcinoma of thyroid

A type of thyroid cancer that makes up about 3% of thyroid cancers.

Understanding Hurthle cell carcinoma of thyroid

Hurthle cell carcinoma of the thyroid is a type of thyroid cancer, also called oxyphil cell tumor.

It makes up about 3% of all thyroid cancers. It is classed as a variant of follicular thyroid tumors. Compared with them, it is more often found in more than one spot, somewhat more aggressive, and less likely to take up iodine.

Signs & symptoms

GARD doesn't list specific symptoms for this condition yet.

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Your doctor may refer you to a specialist who knows rare conditions.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

Care & treatment

Care team
A doctor familiar with rare conditions, plus specialists as needed
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with American Cancer Society
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What stage is my cancer, and what are my treatment options?
Does it take up iodine, and how does that affect treatment?
What follow-up scans or tests will I need?

Quick facts

GARD doesn't describe a cause for this condition yet.

Also known as: cancer of thyroid, hurthle cell; hurthle cell carcinoma of the thyroid; hurthle cell carcinoma of the thyroid gland; hurthle cell carcinoma of thyroid gland; hurthle cell thyroid gland carcinoma; hurthle cell thyroid neoplasia

Patient organizations

Source: NIH GARD · Hurthle cell carcinoma of thyroidGARD ID 9428 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Hurthle cell carcinoma of thyroid.

Explore the Hurthle cell carcinoma of thyroid blog

Explore research for Hurthle cell carcinoma of thyroid

Explore actively recruiting Hurthle cell carcinoma of thyroid studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Hurthle cell carcinoma of thyroid with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Hurthle cell carcinoma of thyroid studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Hurthle cell carcinoma of thyroid

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Hurthle cell carcinoma of thyroid

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Hurthle cell carcinoma of thyroid experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.